Comparison of the performance of four staging systems in determining the prognosis of breast cancer among women undergoing neoadjuvant chemotherapy

ConclusionThe PS, CPS  + EG and Neo-Bioscore staging systems were proven to be equivalent to predict the prognosis of patients undergoing neoadjuvant chemotherapy.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research